ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martín‐Loeches, Richard G. Wunderink, Antoni Torres et al.|Intensive Care Medicine|2023Cited by 289
635. Efficacy, Pharmacokinetics (PK), and Safety Profile of MEDI3902, an Anti-<i>Pseudomonas aeruginosa</i> Bispecific Human Monoclonal Antibody in Mechanically Ventilated Intensive Care Unit Patients; Results of the Phase 2 EVADE Study Conducted by the Public-Private COMBACTE-MAGNET Consortium in the Innovative Medicines Initiative (IMI) ProgramJean Chastre, Hasan S. Jafri, Bruno François et al.|Open Forum Infectious Diseases|2020Cited by 16
Correction to: Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort studyAnahita Rouzé, François Aptel, Matthieu Metzelard et al.|Intensive Care Medicine|2021Cited by 5
Incidence, timing, and outcomes of tracheostomy in COVID-19 acute respiratory distress syndrome patients across three nations—an individual patient data analysisDavid M. P. van Meenen, Carolina Cáfaro, Paula Rodrigues Sanches et al.|Journal of Thoracic Disease|2025Cited by 0